CVRx, Inc. CVRX
0.63 USD -0.07 (-10.01%)
At closeNov 12, 2026, 4:02 PM EST
0.63 0.00 0.00%
After hours · Nov 12, 4:02 PM ET
0.6301 Day range 0.7011
0.6301 52-week range 10.28
- YTD
- -91.13%
- 1 year
- -93.38%
News
newsfilecorp.com ROSEN, SKILLED INVESTOR COUNSEL, Encourages CVRx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVRX New York, New York--(Newsfile Corp. - November 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of CVRx,…
newsfilecorp.com Kaplan Fox Encourages CVRx, Inc. (CVRX) Investors with Significant Losses to Contact the Firm Before January 8, 2027 New York, New York--(Newsfile Corp. - November 12, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX)…
feeds.newsfilecorp.com ROSEN, LEADING INVESTOR COUNSEL, Encourages CVRx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVRX New York, New York--(Newsfile Corp. - November 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces
prnewswire.com CVRX Shareholder Alert: January 8, 2027 Lead Plaintiff Deadline in CVRx, Inc. Securities Class Action - Contact Levi & Korsinsky Executive Accountability: Robert John Named in Securities Action. Shareholders allege misrepresented sales force stability and improper Barostim sales practices at CVRx, and the 18-month hiring wave…
newsfilecorp.com SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against CVRx, Inc. (CVRX) - Investors Who Suffered Losses Are Encouraged to Contact the Firm Lead Plaintiff Deadline: January 8, 2027. Investors who purchased (NASDAQ: CVRX) securities between July 25, 2023 and August 6, 2026 may be eligible to recover losses.
businesswire.com Securities Fraud Class Action Filed Against CVRx, Inc.: Glancy Prongay Wolke & Rotter LLP Announces Lead Plaintiff Deadline LOS ANGELES--(BUSINESS WIRE)--A securities fraud class action lawsuit has been filed against CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) on behalf of investors who purchased or otherwise…
businesswire.com Securities Fraud Class Action Lawsuit Pending Against CVRx, Inc.: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline BENSALEM, Pa.--(BUSINESS WIRE)--CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise…
prnewswire.com HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx, Inc. (CVRX) Investors with Substantial Losses to Contact Firm, Securities Class Action Filed SAN FRANCISCO, Nov. 11, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights litigation firm, alerts investors in CVRx, Inc. (NASDAQ: CVRX) to a class action lawsuit filed in federal…
globenewswire.com ROSEN, LEADING INVESTOR COUNSEL, Encourages CVRx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVRX NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of CVRx, Inc. (NASDAQ:…
globenewswire.com Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against CVRx, Inc. (CVRX) NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Minnesota…
businesswire.com Rosen Law Firm Urges CVRx, Inc. (NASDAQ: CVRX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of CVRx, Inc. (NASDAQ: CVRX) between July 25,…
businesswire.com Securities Fraud Lawsuit Filed Against CVRx, Inc.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) on behalf of investors who purchased or otherwise acquired…
businesswire.com Securities Class Action Filed Against CVRx, Inc. – CVRX Investors Encouraged to Contact Kirby McInerney LLP NEW YORK--(BUSINESS WIRE)---- $CVRX #ClassActionLawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired CVRx, Inc.…
globenewswire.com SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against CVRx, Inc. (NASDAQ: CVRX) — Investors Who Suffered Losses Are Encouraged to Contact the Firm New class action for CVRx, Inc. (CVRX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/8/2027
prnewswire.com CVRX INVESTOR ALERT: Securities Class Action Filed, Hagens Berman Urges CVRx, Inc. Investors with Substantial Losses to Contact Firm Ahead of January 8, 2027 Lead Plaintiff Deadline SAN FRANCISCO, Nov. 10, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights litigation firm, alerts investors in CVRx, Inc. (NASDAQ: CVRX) to a class action lawsuit filed in federal…
newsfilecorp.com Kaplan Fox & Kilsheimer LLP Alerts CVRx, Inc. (CVRX) Investors to a Securities Class Action Deadline on January 8, 2027 New York, New York--(Newsfile Corp. - November 10, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX)…
businesswire.com Investor Alert: Robbins LLP Informs Investors of the CVRx, Inc. Class Action Lawsuit SAN DIEGO--(BUSINESS WIRE)---- $CVRX #CVRX--CVRx allegedly misled investors regarding misconduct that exposed the company to liability under the False Claims Act and Anti-Kickback Statute.
globenewswire.com HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx, Inc. (CVRX) Investors with Substantial Losses to Contact Firm, Securities Class Action Filed SAN FRANCISCO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Hagens Berman, a national shareholder rights litigation firm, alerts investors in CVRx, Inc. (NASDAQ: CVRX) to a class action lawsuit filed in federal…
globenewswire.com Berman Tabacco Files Securities Class Action Lawsuit Against CVRx, Inc. (CVRX) SAN FRANCISCO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Berman Tabacco (www.bermantabacco.com), a national law firm representing investors, filed a class action lawsuit in the U.S. District Court for the…
benzinga.com Lake Street Maintains Hold on CVRx, Lowers Price Target to $1.5 Lake Street analyst Frank Takkinen maintains CVRx (NASDAQ:CVRX) with a Hold and lowers the price target from $3.5 to $1.5.
seekingalpha.com CVRx, Inc. (CVRX) Q3 2026 Earnings Call Transcript CVRx, Inc. ( CVRX ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Kevin Hykes - President, CEO & Director John Landry - Chief Financial Officer Jared Oasheim - Consultant…
benzinga.com Canaccord Genuity Downgrades CVRx to Hold, Lowers Price Target to $2 Canaccord Genuity analyst William Plovanic downgrades CVRx (NASDAQ:CVRX) from Buy to Hold and lowers the price target from $5 to $2.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Obsidian Therapeutics (NASDAQ:OBX) stock increased by 27.7% to $12.26 during Friday's regular session. The company's market cap stands at $593.0 million. TransMedics Group (NASDAQ:TMDX)…
benzinga.com Nasdaq Jumps 400 Points; US Nonfarm Payrolls Top Estimates In October U.S. stocks were mixed: Nasdaq +1.75%, S&P +0.99%, Dow -0.21%, as October jobs beat forecasts; oil rose, while global markets mostly fell.
zacks.com CVRx (CVRX) Reports Q3 Loss, Lags Revenue Estimates CVRx (CVRX) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to a loss of $0.49 per share a year ago.
zacks.com Here's What Key Metrics Tell Us About CVRx (CVRX) Q3 Earnings While the top- and bottom-line numbers for CVRx (CVRX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare…
benzinga.com CVRx Lowers FY2026 Sales Guidance from $58.000M-$60.000M to $56.000M-$57.000M vs $58.950M Est CVRx (NASDAQ:CVRX) lowers FY2026 sales outlook from $58.000 million-$60.000 million to $56.000 million-$57.000 million vs $58.950 million estimate.
globenewswire.com CVRx Reports Third Quarter 2026 Financial and Operating Results MINNEAPOLIS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative…
benzinga.com CVRx Reports Q2 2026 Results: Full Earnings Call Transcript On Thursday, CVRx (NASDAQ:CVRX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday's regular session. Tenon Medical (NASDAQ:TNON) stock increased by 47.25% to $4.02. The market value of…
benzinga.com CVRx To Present Barostim Data And Clinical Research At HFSA Annual Scientific Meeting 2026 CVRx, Inc. (NASDAQ:CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced…
benzinga.com CVRx Appoints John Landry CFO, Effective Oct. 12, Succeeding Jared Oasheim CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with…- benzinga.com CVRx Shareholder Urges Board To Launch Sale Process To Unlock Barostim’s Strategic Value Delivers Letter to the CVRx Board Highlighting Significant Value Proposition of Barostim to a Large Medical Device Company with Established Infrastructure to Capitalize on the Product's Market…
benzinga.com Cantor Fitzgerald Maintains Overweight on CVRx, Lowers Price Target to $5 Cantor Fitzgerald analyst Sarah James maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $13 to $5.
benzinga.com Lake Street Downgrades CVRx to Hold, Lowers Price Target to $3.5 Lake Street analyst Frank Takkinen downgrades CVRx (NASDAQ:CVRX) from Buy to Hold and lowers the price target from $14 to $3.5.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report…
benzinga.com Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket Atlassian Corp (NASDAQ: TEAM) reported strong Q4 results, beating revenue and earnings estimates. Stock jumped 30.7% in pre-market trading.
benzinga.com CVRx Stock Is Falling Overnight: Here's What's Driving the Move CVRx stock sinks after hours after lowering full-year revenue outlook despite revenue growth.- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings…
- benzinga.com CVRx Lowers FY2026 Sales Guidance from $63.000M-$67.000M to $58.000M-$60.000M vs $65.340M Est CVRx (NASDAQ:CVRX) lowers FY2026 sales outlook from $63.000 million-$67.000 million to $58.000 million-$60.000 million vs $65.340 million estimate.
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Earnings Scheduled For May 11, 2026 - benzinga.com Earnings Scheduled For February 12, 2026
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Earnings Scheduled For August 4, 2025 - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday 
benzinga.com Earnings Scheduled For May 8, 2025 - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session